Astellas touts 2-year trial of geographic atrophy drug Izervay, but questions remain
kdunleavy
Tue, 09/19/2023 – 10:48
Source link
Receive industry updates via newsletters. Subscribe now.
Be Resourceful, Be Updated.
Welcome Insider. Check you inbox / spam box for welcome message. Thankyou ! (Don't forget to mark the Email as safe.)
Please try again.